Skip to product information
1 of 2

MediHerb

MediHerb Astragalus Complex 60 Tablets

MediHerb Astragalus Complex 60 Tablets

Regular price $99.95
Regular price Sale price $99.95
Sale Sold out
Tax included. Shipping calculated at checkout.

 

MediHerb Astragalus Complex contains astragalus, echinacea purpurea root, and Siberian ginseng. This combination of herbs provides temporary relief for the symptoms associated with the common cold, the flu, and infections in the upper respiratory tract.

Feature

  • Echinacea root is traditionally used in Western herbal medicine to help stimulate a healthy immune system response and enhance immune system function
  • Astragalus, Echinacea and Siberian Ginseng Support the immune system to fight illness
  • Siberian Ginseng assists the body to cope with environmental stress, supports mental and physical capacity, and aids recovery from illness

Dose:

Adults: 1 tablet 2-4 times daily

Ingredients:

Each tablet contains:  
Astragalus membranaceus (Astragalus) extract 1.7 mL
derived from root dry 850 mg
Eleutherococcus senticosus (Siberian Ginseng) extract 75 mg
derived from min. root dry 750 mg
 standardised to contain syringaresinol glucosides 600 mcg
Echinacea purpurea (Echinacea) extract 1.3 mL
 derived from root dry 650 mg

Calcium Hydrogen Phosphate Dihydrate, Colloidal Anhydrous Silica, Croscarmellose Sodium, Hypromellose, Magnesium Stearate, Microcrystalline Cellulose, Sodium Starch Glycollate.

No added: Gluten, soya bean, milk, lactose, peanuts, tree nuts, fish, crustacea, egg, sesame seeds, artificial sweeteners, colours or flavours

Suitable for vegans and vegetarians

Warning:

  1. Discontinue during an acute infectious illness or mild fever since the tonic and warming properties of Astragalus and Siberian Ginseng may aggravate the illness
  2. The risk of allergic reaction to Echinacea is very small, especially if root preparation is used since these are free of pollens.
  3. Echinacea is contraindicated in patients taking immunosuppressant medication (e.g. transplant patients). Therefore, short-term therapy only is suggested in this instance.
  4. Caution is advised in patients receiving midazolam by injection
  5. Not to be used in children under two years of age without medical advice
  6. Discontinue 7 days prior to general anaesthesia
  7. If patient symptoms persist, seek additional professional advice.
View full details